OBJECTIVE: We review the uses of electronic health care data algorithms, measures of their accuracy, and reasons for prioritizing one measure of accuracy over another. STUDY DESIGN AND SETTING: We use real studies to illustrate the variety of uses of automated health care data in epidemiologic and health services research. Hypothetical examples show the impact of different types of misclassification when algorithms are used to ascertain exposure and outcome. RESULTS: High algorithm sensitivity is important for reducing the costs and burdens associated with the use of a more accurate measurement tool, for enhancing study inclusiveness, and for ascertaining common exposures. High specificity is important for classifying outcomes. High positive predictive value is important for identifying a cohort of persons with a condition of interest but that need not be representative of or include everyone with that condition. Finally, a high negative predictive value is important for reducing the likelihood that study subjects have an exclusionary condition. CONCLUSION: Epidemiologists must often prioritize one measure of accuracy over another when generating an algorithm for use in their study. We recommend researchers publish all tested algorithms-including those without acceptable accuracy levels-to help future studies refine and apply algorithms that are well suited to their objectives.
OBJECTIVE: We review the uses of electronic health care data algorithms, measures of their accuracy, and reasons for prioritizing one measure of accuracy over another. STUDY DESIGN AND SETTING: We use real studies to illustrate the variety of uses of automated health care data in epidemiologic and health services research. Hypothetical examples show the impact of different types of misclassification when algorithms are used to ascertain exposure and outcome. RESULTS: High algorithm sensitivity is important for reducing the costs and burdens associated with the use of a more accurate measurement tool, for enhancing study inclusiveness, and for ascertaining common exposures. High specificity is important for classifying outcomes. High positive predictive value is important for identifying a cohort of persons with a condition of interest but that need not be representative of or include everyone with that condition. Finally, a high negative predictive value is important for reducing the likelihood that study subjects have an exclusionary condition. CONCLUSION: Epidemiologists must often prioritize one measure of accuracy over another when generating an algorithm for use in their study. We recommend researchers publish all tested algorithms-including those without acceptable accuracy levels-to help future studies refine and apply algorithms that are well suited to their objectives.
Authors: Annette B Beiderbeck; Elizabeth A Holly; Miriam C J M Sturkenboom; Jan W W Coebergh; Bruno H Ch Stricker; Hubert G M Leufkens Journal: Am J Epidemiol Date: 2003-03-15 Impact factor: 4.897
Authors: Kristin L Nichol; James Nordin; John Mullooly; Richard Lask; Kelly Fillbrandt; Marika Iwane Journal: N Engl J Med Date: 2003-04-03 Impact factor: 91.245
Authors: Craig C Earle; Ann B Nattinger; Arnold L Potosky; Kathleen Lang; Rajiv Mallick; Mark Berger; Joan L Warren Journal: Med Care Date: 2002-08 Impact factor: 2.983
Authors: Tiffany L Gary; Marian Batts-Turner; Lee R Bone; Hsin-Chieh Yeh; Nae-Yuh Wang; Felicia Hill-Briggs; David M Levine; Neil R Powe; Martha N Hill; Christopher Saudek; Maura McGuire; Frederick L Brancati Journal: Control Clin Trials Date: 2004-02
Authors: Miriam G Cisternas; Louise Murphy; Jeffrey J Sacks; Daniel H Solomon; David J Pasta; Charles G Helmick Journal: Arthritis Care Res (Hoboken) Date: 2016-05 Impact factor: 4.794
Authors: Sophia R Newcomer; Stan Xu; Martin Kulldorff; Matthew F Daley; Bruce Fireman; Jason M Glanz Journal: J Am Med Inform Assoc Date: 2019-12-01 Impact factor: 4.497
Authors: Tiansheng Wang; Jeff Y Yang; John B Buse; Virginia Pate; Huilin Tang; Edward L Barnes; Robert S Sandler; Til Stürmer Journal: Diabetes Care Date: 2019-08-30 Impact factor: 19.112
Authors: Sophia R Newcomer; Martin Kulldorff; Stan Xu; Matthew F Daley; Bruce Fireman; Edwin Lewis; Jason M Glanz Journal: Pharmacoepidemiol Drug Saf Date: 2018-01-02 Impact factor: 2.890
Authors: Deirdre A Hill; Jennifer S Haas; Robert Wellman; Rebecca A Hubbard; Christoph I Lee; Jennifer Alford-Teaster; Karen J Wernli; Louise M Henderson; Natasha K Stout; Anna N A Tosteson; Karla Kerlikowske; Tracy Onega Journal: J Gen Intern Med Date: 2017-12-06 Impact factor: 5.128